Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$257.11 - $319.92 $922,767 - $1.15 Million
-3,589 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$268.3 - $380.31 $987,880 - $1.4 Million
-3,682 Reduced 50.64%
3,589 $988,000
Q4 2020

Feb 16, 2021

SELL
$248.13 - $308.36 $1.03 Million - $1.28 Million
-4,145 Reduced 36.31%
7,271 $2.14 Million
Q3 2020

Nov 13, 2020

SELL
$215.51 - $272.51 $341,367 - $431,655
-1,584 Reduced 12.18%
11,416 $3 Million
Q2 2020

Aug 14, 2020

BUY
$127.44 - $232.72 $637,200 - $1.16 Million
5,000 Added 62.5%
13,000 $2.93 Million
Q1 2020

May 15, 2020

SELL
$108.83 - $165.23 $54,415 - $82,615
-500 Reduced 5.88%
8,000 $1.05 Million
Q4 2019

Feb 14, 2020

BUY
$106.59 - $164.21 $906,015 - $1.4 Million
8,500 New
8,500 $1.36 Million
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $1.04 Million - $1.27 Million
-9,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$98.85 - $134.59 $889,650 - $1.21 Million
9,000 New
9,000 $1.12 Million
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $701,910 - $1.21 Million
-11,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $604,000 - $773,040
8,000 Added 266.67%
11,000 $834,000
Q2 2018

Jul 19, 2018

BUY
$74.84 - $100.16 $74,840 - $100,160
1,000 Added 50.0%
3,000 $249,000
Q1 2018

May 10, 2018

BUY
$56.95 - $85.19 $113,900 - $170,380
2,000 New
2,000 $161,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.